Imactiv-3D will be at Elrig meeting in Lyon on 29 and 30 November. Come and meet us at our booth in the Startup area.
Imactiv-3D will be at TEDD Annual Meeting in Zurich October 27, 2016. Feel free to come and discuss with us your needs.
Discover our first film for viewing a 3D mouse heart, in our Gallery. First step in characterizing the effect of treatment on models of cardiac pathologies.
Capitalizing know-how and inventions from academic research by company creation. This is the goal that has set the Institute of Advanced Technologies in Life Sciences (ITAV).
And that’s what makes the 3D-IMACTIV company offering service and expertise in research and development for evaluation by imaging and quantitative image analysis of 3D models, tissue or organ to accompany customers in decision making.
I contacted IMACTIV 3D in order to image the ability of small molecules to protect the mouse heart damage from ischemia-reperfusion injury. Contacts with the founder and collaborators IMACTIV3D were easy and fluid. They were very receptive to our requests. We are now very pleased and impressed with their results. Eventually, they far exceed those achieved with the approaches traditionally used in the laboratory and will prove superior in terms of information, quantification and will reduce the number of animals.
Valérie holds a PhD from the University of Toulouse and she is lecturer in cell and developmental biology. Valérie is a cancer biology specialist, and is co-leader of the team « Innovation for the study of cell proliferation in 3D – IP3D » at the Institute of Advanced Technologies in Life sciences.
She brings to the company her expertise in handling and multimodal exploration of 3D models, especially for spatial-temporal exploration by 3D imaging techniques.
Jean-Michel is an Engineer in optics and image analysis, graduated of the National School of Physics of Marseille in 1990. He has over 20 years experience as project manager and head of a unit research in Imaging and Engineering of the skin in the Pierre Fabre Laboratories. After a first experience as Founder and President of a first company in 2012 in the field of aid in the early detection of melanoma, he now devotes to the development of Imactiv-3D bringing his skills in imaging, image treatment and corporate management.